Name: Bright Minds Biosciences Inc. (DRUG) Balance Sheet
Creator: FinSpry

Bright Minds Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions CAD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Bright Minds Biosciences Inc. (DRUG) - Annual data in millions CAD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Current Assets
Cash and Cash Equivalents	82.91	5.72	6.75	11.63	19.76
Short-Term Investments	0.09	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	82.91	5.72	6.75	11.63	19.76
Accounts Receivable	0.41	0.05	0.04	0.16	0.11
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.99	0.22	0.03	0.16	0.17
Total Current Assets	84.31	5.99	6.81	11.95	20.04
Non-Current Assets
Property, Plant & Equipment (Net)	0.11	0.12	0.07	0.14	0.00
Intangible Assets	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.11	0.12	0.07	0.14	0.00
Total Assets	84.42	6.10	6.88	12.09	20.04
Current Liabilities
Accounts Payable	1.71	0.41	0.21	1.25	0.60
Short-Term Debt	0.17	0.00	0.00	0.00	0.00
Accrued Liabilities	0.54	0.04	0.03	0.16	0.04
Other Current Liabilities	0.46	0.00	0.00	0.00	0.00
Total Current Liabilities	2.34	0.53	0.28	1.47	0.64
Non-Current Liabilities
Long-Term Debt	0.04	0.04	0.00	0.07	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	34.72	0.00
Total Non-Current Liabilities	0.04	0.04	0.00	0.07	0.00
Total Liabilities	2.38	0.57	0.28	1.54	0.64
Stockholders' Equity
Common Stock	123.25	35.42	33.91	32.24	27.08
Retained Earnings	-46.58	-34.35	-31.55	-24.17	-9.21
Accumulated Other Comprehensive Income	5.37	4.46	3.40	2.48	1.53
Shares Outstanding	7.64	4.52	3.77	3.52	0.00
Total Stockholders' Equity	82.04	5.54	6.60	10.54	19.40
Total Liabilities & Equity	84.42	6.10	6.88	12.09	0.00